Mannatech, Incorporated (MTEX) | Investment Case

1. Company Snapshot

1.a. Company Description

Mannatech, Incorporated operates as a health and wellness company worldwide.It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products.The company primarily sells its products directly, as well as through e-commerce and network marketing channels.

Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Show Full description

1.b. Last Insights on MTEX

Mannatech's recent performance was driven by strategic leadership enhancements, with the promotion of Peter Griscom to Chief Operating Officer, effective July 1, 2025. This appointment brings over 10 years of experience in the direct selling channel and expertise in launching, leading, and restructuring companies, creating efficiencies in manufacturing, sales, and marketing. This move is expected to bolster the company's operational capabilities and drive future growth.

1.c. Company Highlights

Last Price	9.64
Change Percentage	3.66%
Open	9.3
Previous Close	9.3
Market Cap ( Millions)	18
Volume	1003
Year High	16.49
Year Low	7.5
M A 50	9.27
M A 200	9.42

FCF Yield	-12.54%
Dividend Yield	0.00%
ROE	-22.75%
Debt / Equity	87.27%
Net Debt / EBIDTA	-71.83%
Price To Book	2.64
Price Earnings Ratio	-11.07
Price To FCF	-7.97
Price To sales	0.17
EV / EBITDA	11.51

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Mannatech Reports Financial Results for Third Quarter 2025

Nov -12

Source: globenewswire.com

Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer

Jun -26

Source: businesswire.com

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of Directors

Nov -26

Source: businesswire.com

Mannatech Reports Financial Results for Second Quarter 2024

Aug -13

Source: businesswire.com

Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

Jul -01

Source: businesswire.com

Mannatech Reports Financial Results for First Quarter 2024

May -14

Source: businesswire.com

Charting New Paths: Mannatech Expanding with Thailand Office, Grand Opening, September 2024

Apr -24

Source: headlinesoftoday.com

Charting New Paths: Mannatech Expanding with Thailand Office, Grand Opening, September 2024

Apr -24

Source: businesswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.27%)

6. Segments

Nutritional Supplements, Skin Care and Anti-aging Products

Expected Growth: 7.4%

Growing demand for healthy aging and wellness products, increasing awareness of preventative healthcare, and expanding online sales channels drive growth in the nutritional supplements and skin care market.

Pack and Associated Fees

Expected Growth: 4.5%

Growing demand for health and wellness products, increasing popularity of direct sales business models, and Mannatech's expanding global presence drive growth in the starter kit market.

Other

Expected Growth: 7.4%

Growing demand for immune-boosting supplements, increasing awareness of glyconutrients' benefits, and Mannatech's proprietary blend Ambrotose driving growth in the nutritional supplements market.

7. Detailed Products

Ambrotose

A line of glyconutritional products that support immune system function and overall health

Phytomax

A line of plant-based nutritional supplements that provide antioxidants and other nutrients

Emprizone

A line of antioxidant supplements that support immune system function and overall health

GlycoCafe

A line of glyconutritional coffee products that provide a boost of energy and support immune system function

Manna-Tech

A line of nutritional supplements that provide antioxidants, vitamins, and minerals

AmbroStart

A line of glyconutritional products that support immune system function and overall health in children

Sport

A line of nutritional supplements that support athletic performance and recovery

Uth

A line of skincare products that promote healthy skin and reduce the signs of aging

8. Mannatech, Incorporated's Porter Forces

Forces Ranking

Threat Of Substitutes

Mannatech's products are moderately substitutable, as customers can opt for alternative health and wellness products from other companies.

Bargaining Power Of Customers

Mannatech's customers have limited bargaining power due to the company's strong brand reputation and loyalty programs.

Bargaining Power Of Suppliers

Mannatech's suppliers have moderate bargaining power, as the company relies on a diverse range of suppliers for its ingredients and manufacturing processes.

Threat Of New Entrants

The health and wellness industry is highly competitive, and new entrants can easily enter the market, posing a significant threat to Mannatech's market share.

Intensity Of Rivalry

The health and wellness industry is highly competitive, with many established players competing for market share, leading to a high intensity of rivalry.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

	Value
Debt Weight	35.32%
Debt Cost	3.95%
Equity Weight	64.68%
Equity Cost	9.77%
WACC	7.72%
Leverage	54.62%

11. Quality Control: Mannatech, Incorporated passed 2 out of 9 key points

Strong Liquidity

Low Deb

Strong Interest Coverage

Healthy Cash Flow

Operating Efficiency

Strong Return On Equity

Consistent Revenue Growth

Consistent Operating Cash Flow Growth

Margin Improvement

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Nu Skin

A-Score: 5.9/10

Value: 8.5

Growth: 2.2

Quality: 6.4

Yield: 5.0

Momentum: 10.0

Volatility: 3.0

1-Year Total Return ->

Acme United

A-Score: 4.8/10

Value: 3.8

Growth: 4.8

Quality: 6.3

Yield: 4.0

Momentum: 4.0

Volatility: 5.7

1-Year Total Return ->

Mannatech

A-Score: 4.7/10

Value: 8.6

Growth: 2.1

Quality: 4.4

Yield: 4.0

Momentum: 8.0

Volatility: 1.3

1-Year Total Return ->

Edgewell

A-Score: 4.3/10

Value: 6.6

Growth: 3.9

Quality: 3.8

Yield: 5.0

Momentum: 0.5

Volatility: 6.0

1-Year Total Return ->

Grove Collaborative

A-Score: 4.3/10

Value: 8.2

Growth: 4.7

Quality: 4.0

Yield: 0.0

Momentum: 7.0

Volatility: 1.7

1-Year Total Return ->

European Wax Center

A-Score: 4.0/10

Value: 6.8

Growth: 5.2

Quality: 5.3

Yield: 3.0

Momentum: 1.5

Volatility: 2.3

1-Year Total Return ->

Peers Metrics

12.e Scoring ^Insights

12.f DCF ^BETA

Parameters

Short Term Growth

27.20%

Short term Time

10.0

Long-Term Growth

2.00%

WACC

7.72%

Mannatech, Incorporated - US5637712036

1. Company Snapshot

1.a. Company Description

1.b. Last Insights on MTEX

1.c. Company Highlights

Lower Growth

Higher Yield

Cheaper

More Volatile

Weak Momentum

Fairly Valued

Medium Volatility

Stable Momentum

Strong Momentum

Better Quality

2. Transcript Summary

3. NewsRoom

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.27%)

6. Segments

Nutritional Supplements, Skin Care and Anti-aging Products

Expected Growth: 7.4%

Pack and Associated Fees

Expected Growth: 4.5%

Other

Expected Growth: 7.4%

7. Detailed Products

Ambrotose

Phytomax

Emprizone

GlycoCafe

Manna-Tech

AmbroStart

Sport

Uth

8. Mannatech, Incorporated's Porter Forces

Forces Ranking

Threat Of Substitutes

Bargaining Power Of Customers

Bargaining Power Of Suppliers

Threat Of New Entrants

Intensity Of Rivalry

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

11. Quality Control: Mannatech, Incorporated passed 2 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

9.64$

Current Price

9.64$

Potential

-0.00%

Expected Cash-Flows

12.e Scoring ^Insights

12.f DCF ^BETA